Wait goes on for regulation in South Africa
This article was originally published in RAJ Devices
The promise of a system of device and in vitro diagnostics regulation is still very much alive in South Africa, even if the timelines remain sketchy.
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Royal Philips closed out the first year of COVID-19 with 7% revenue growth in the fourth quarter. CEO Frans van Houten says low single digit growth is the target for fiscal 2021.
There can be no such thing as a COVID dividend, but the renewed digital push and momentum for health system change perhaps come closest.